key: cord-0973485-4whjir09
authors: Larson, Sharon Beth; Watson, Sarah N.; Eberlein, Michael; Simmons, Jonathan S.; Doerschug, Kevin C.; Leslie, Kimberly K.
title: Survival of Pregnant Coronavirus Patient on Extracorporeal Membrane Oxygenation
date: 2020-10-09
journal: Ann Thorac Surg
DOI: 10.1016/j.athoracsur.2020.09.004
sha: d73141db3d752b84d0c2e8a4f8aa17844fd1b998
doc_id: 973485
cord_uid: 4whjir09

A 27-year-old female presented at 23 weeks 6 days gestation that tested positive for the coronavirus disease 2019 (COVID-19). Despite mechanical ventilation and paralysis, she remained hypoxic and was emergently cannulated for veno-venous extracorporeal membrane oxygenation (VV ECMO). The patient ambulated while intubated and on VV ECMO. She was decannulated and extubated. An ultrasound demonstrated an appropriately grown fetus without abnormalities. She was discharged to home and gave birth to a healthy baby girl at 39 weeks gestation. Utilizing VV ECMO, this patient and her fetus survived acute hypoxemic respiratory failure due to COVID-19.

Information regarding the impact of coronavirus disease 2019 (COVID-19) on pregnant women who require veno-venous extracorporeal membrane oxygenation (VV ECMO) is limited. This case describes the survival of a pregnant patient with COVID-19 who was successfully discharged to her home and had a healthy birth after treatment including VV ECMO.

The patient is a 27-year-old female who presented with a history of fever, cough, and sore throat at 23 weeks 6 days gestation. She tested positive for COVID-19 and presented to the emergency room with new onset nausea, vomiting, and shortness of breath. Risk factors included work at a long-term care facility. The patient's past medical history included one prior Cesarean section with arrest of descent at term and history of postpartum pre-eclampsia. Her pregnancy otherwise had been uncomplicated. She had a mild transaminitis, hypokalemia, and proteinuria. The patient had a witnessed tonic-clonic seizure accompanied by urinary incontinence followed by a post-ictal state. Exam revealed no evidence of preterm labor or rupture of membranes. The patient was emergently intubated. A chest x-ray revealed right lower lobe consolidation and bilateral patchy infiltrates. The patient was transferred to our facility for management of her respiratory distress secondary to COVID-19 given the potential for premature delivery requiring neonatal intensive care unit management of a periviable fetus.

She was admitted to the medical intensive care unit (MICU) in acute hypoxemic respiratory failure due to acute respiratory distress syndrome (ARDS) secondary to COVID-19. Prone positioning was not possible, so the patient was paralyzed to promote better patient synchrony with lung protective mechanical ventilation under sedation. She remained hypoxic on ventilator settings with a fraction of inspired oxygen of 100% and a positive end-expiratory pressure of 16 mmHg. Her ratio of arterial oxygen partial pressure to fractional inspired oxygen was 66 mmHg and it was determined that the patient would need emergent VV ECMO.

A multidisciplinary discussion was had concerning whether delivery was indicated given her acutely worsening status. Given the patient had been normotensive throughout her course, her seizure was not felt to be consistent with eclampsia. There was no clear evidence that delivery at this gestational age would improve maternal respiratory status in the setting of ARDS and COVID-19 pneumonia. The fetal survival on extracorporeal membrane oxygenation was considered better than a periviable delivery. The risk of severe hemorrhage after emergent cesarean delivery given the need for anticoagulation at cannulation and initiation was discussed. The decision was made to pursue delivery while on support for maternal indications only.

The patient was taken emergently to the operating room for cannulation and initiation of VV There is growing evidence that anticoagulation of patients with COVID-19 leads to better outcomes. The current recommendation is to follow the institutional guidelines for anticoagulation on extracorporeal membrane oxygenation for COVID-19 as in other disease states. 7 Convalescent plasma has been utilized in the treatment of patients with COVID-19, was well tolerated, and could potentially improve the outcomes in severe COVID-19 cases. Convalescent plasma has previously been delivered to a pregnant patient critically ill with COVID-19 on extracorporeal membrane oxygenation support with complete recovery. 8 J o u r n a l P r e -p r o o f

Clinical Characteristics of Pregnant Women with COVID-19 in Wuhan, China

Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients

Extracorporeal membrane oxygenation in pregnant and postpartum women with H1N1-related acute respiratory distress syndrome: a systematic review and meta-analysis

Extracorporeal membrane oxygenation (ECMO) during pregnancy and postpartum

Bayona-Molano Mdel P. Challenges in interventional radiology: The pregnant patient

Extracorporeal Membrane Oxygenation in Pregnant and Postpartum Women: A Systematic Review and Meta-Regression Analysis

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Effectiveness of convalescent plasma therapy in severe COVID-19 patients